ANTIMICROBIAL RELATED LIS CANNED MESSAGES

Similar documents
TABLE OF CONTENTS. Urine - Gram Positive Susceptibility Reporting 1 Staphylococcus species, MRSA...11

Antimicrobial Susceptibility Testing: Advanced Course

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Policy # MI_AST Department of Microbiology. Page Quality Manual

2015 Antibiotic Susceptibility Report

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Antimicrobial susceptibility

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

2016 Antibiotic Susceptibility Report

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

CONTAGIOUS COMMENTS Department of Epidemiology

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

RCH antibiotic susceptibility data

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

Intrinsic, implied and default resistance

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

CONTAGIOUS COMMENTS Department of Epidemiology

Concise Antibiogram Toolkit Background

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

European Committee on Antimicrobial Susceptibility Testing

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

Leveraging the Lab and Microbiology Department to Optimize Stewardship

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

National Surveillance of Antimicrobial Resistance

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Understanding the Hospital Antibiogram

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Antimicrobial Susceptibility Testing: The Basics

2015 Antimicrobial Susceptibility Report

European Committee on Antimicrobial Susceptibility Testing

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Cipro for gram positive cocci in urine

January 2014 Vol. 34 No. 1

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

Approach to pediatric Antibiotics

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Antimicrobial Resistance Trends in the Province of British Columbia. August Epidemiology Services British Columbia Centre for Disease Control

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Resistance Trends in the Province of British Columbia

CONTAGIOUS COMMENTS Department of Epidemiology

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Antibacterial Resistance In Wales

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Principles of Antibiotics Use & Spectrum of Some

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Advanced Practice Education Associates. Antibiotics

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

CUMULATIVE ANTIBIOGRAM

BSAC standardized disc susceptibility testing method (version 8)

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

microbiology testing services

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

EUCAST recommended strains for internal quality control

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

CONTAGIOUS COMMENTS Department of Epidemiology

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Performance Information. Vet use only

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

EARS Net Report, Quarter

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Main objectives of the EURL EQAS s

British Society for Antimicrobial Chemotherapy

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ARCH-Vet. Summary 2013

EC Workshop on scientific advice from AMEG

Antibiotic resistance and what can be done

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

January 2014 Vol. 34 No. 1

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Antibacterial Resistance in Wales

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

What s next in the antibiotic pipeline?

What s new in EUCAST methods?

B. PACKAGE LEAFLET 1

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Antibacterial Resistance In Wales

Summary of the latest data on antibiotic resistance in the European Union

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals?

Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance

Transcription:

Policy # MI\ANTI\04\v01 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Antimicrobial Related LIS Canned Issued by: LABORATORY MANAGER Original Date: November 21, 2005 Approved by: Laboratory Director Revision Date: I. Introduction ANTIMICROBIAL RELATED LIS CANNED MESSAGES Antimicrobial related canned messages are built into the Laboratory Information System to provide uniform reporting phrases to be used when certain pre-described conditions are met. II. Procedure A. Automatic Canned : The lists below are automatic canned messages that will appear when set conditions are met. The message will appear in a warning box before exiting an order. 1. When the message code appears, press F12 to save. 2. Continue with another F12 to save the order. 3. View the report. 4. If the same message had been save previously (i.e. appeared more than once), go to the Isolate Comment window, press CTLR and L at the line to remove the duplicate line. 5. Re-status as required. 6. Press F12 to save the order. Ear and Eye specimens with susceptibility results LIS Isolate Canned Message Code: &eye; attached to Organism classes A and B with sources EYE, EYEN, EAR and drugs am, betalac, cc, peng, sxt. These susceptibility testing results are based on guidelines for systemic antimicrobial agents and may not accurately represent activity of topical agents. For MSH MRO s LIS Isolate Canned Message Code: \MRES, attached to drug tax MULTIPLY ANTIBIOTIC RESISTANT ORGANISM. THIS PATIENT MUST BE ON "CONTACT PRECAUTIONS" UNTIL FURTHER NOTICE FROM INFECTION CONTROL. For MSH MRSA s LIS Isolate Canned Message Code: \MRSI, attached to organism staamr THIS PATIENT MUST BE ON "MRSA PRECAUTION" UNTIL FURTHER NOTICE. MRSA isolated from MRSA Screen Susceptibility Result Comment LIS Isolate Canned Message Code: \MRSS; linked to drug code - oxa Susceptibility results are provided to guide decolonization therapy; if decolonization therapy is being considered, please consult your infection control team. Page 26

Policy # MI\ANTI\04\v01 Page 2 of 5 Staphylococcus saprophyticus and CNST from urine LIS Isolate Canned Message Code: \ssap; attached to organism stasap. "Susceptibility testing of this organism is not warranted because infections respond to concentrations achieved in urine of antimicrobial agents commonly used to treat acute, uncomplicated urinary tract infections e.g. nitrofurantoin, trimethoprim/sulfa or fluoroquinolones. ß-haemolytic Streptococcus Groups A, B, C and G LIS Isolate Canned Message Code: \GBS; attached to organism straga, strpyo, strgrc, strgrg. "This organism is intrinsically susceptible to penicillin. If treatment is required AND this patient cannot be treated with penicillin, please contact the Microbiology Department within 48 hours to request sensitivity testing. For MSH VRE s LIS Isolate Canned Message Code: \VREI, attached to organisms entfac and entfae THIS PATIENT MUST BE ON "VRE PRECAUTION" UNTIL FURTHER NOTICE. Vancomycin for E. gallinarum, and E. casseliflavus report as R with the statement LIS Isolate Canned Message Code: \EntV; attached to organisms - entgal and entcas. "This organism always has intrinsic non-transmissible resistance to vancomycin. The patient does not require isolation." For Listeria species: LIS Isolate Canned Message Code: \LIST; attached to organisms lismoc and lismon. Routine in vitro susceptibility testing of this organism is unreliable. Listeria spp. should be considered resistant to all cephalosporins. The recommended regimen for therapy is ampicillin. If additional advice on antimicrobial therapy is required, please contact the Medical Microbiologist. For isolates that for which susceptibility testing is not routinely performed and/or is unreliable: LIS Isolate Canned Message Code: \NSEN; attached to organisms and Isolate Comment keypad. "In vitro susceptibility testing for this organism is not routinely performed and/or is unreliable. If advice on antimicrobial therapy is required, please contact the Medical Microbiologist". Page 27

Policy # MI\ANTI\04\v01 Page 3 of 5 For Cedecea spp., Citrobacter spp., Enterobacter spp., Hafnia spp., Morganella morganii, Pantoea agglonerans, Proteus penneri, Proteus vulgaris, Providencia species, Serratia species that are ceftriaxone or pipercillin/tazobactam = S: LIS Isolate Canned Message Code: &cit or &ent or &ser; attached to Organisms ceddav, cedlap, cedspp, Classes d, e, H, L, S, and T. Resistance to extended-spectrum penicillins, beta-lactam/beta-lactamase inhibitor combinations (e.g. pipercillin/tazobactam), and cephalosporins may develop during therapy with these agents. For serious infections, these agents should be avoided and consultation with a medical microbiologist or infectious disease physician is strongly recommended. For MSH E. coli, Klebsiella species, Proteus Class A ESBL, Infection Control message: Isolate canned message code &taz linked to organisms E. coli, Class J and Class T: MULTIPLY ANTIBIOTIC RESISTANT ORGANISM. THIS PATIENT MUST BE ON "CONTACT PRECAUTIONS" UNTIL FURTHER NOTICE FROM INFECTION CONTROL. ESBL Comments Attached to organisms esccol, Class J and Class T Desbinh=Y Dfox=S ~&cla The susceptibility pattern suggests that this organism contains a class A extended spectrum beta-lactamase (ESBL). Dtaz=R Desbinh=N Dfox=R or I ~&clac The susceptibility pattern suggests that this organism contains a class C extended spectrum beta-lactamase (ESBL). Desbinh=Y Dfox=R or I ~&clac The susceptibility pattern suggests that this organism contains class A and C extended spectrum beta-lactamases (ESBL). Dtaz=R Desbinh=N Dfox=S ~&esbl The susceptibility pattern suggests that this organism contains an extended spectrum beta-lactamase (ESBL) other than class A or C. For Haemophilus species from Respiratory and Miscellaneous Sites LIS Isolate Canned Message Code, attached to organism Class X: If beta-lactamase is negative, \BLa- beta-lactamase negative result suggests susceptible to ampicillin. If beta-lactamase is positive, \BLa+ beta-lactamase positive result suggests resistance to ampicillin but generally susceptible to amoxicillin-clavulanic acid and cefuroxime. Page 28

Policy # MI\ANTI\04\v01 Page 4 of 5 For Salmonella species: Nalidixic acid confirming Fluoroquinolone Susceptibility in Salmonella species Preliminary Report Comment Susceptibility testing suggests that this organism may not be fully susceptible to fluoroquinolones. Further testing is being completed and results will be available tomorrow. If you are interested in preliminary susceptibility results, please contact the microbiology laboratory. Comment after KB Nalidixic Acid has been completed: LIS Isolate Canned Message Code: &sal; attached to organisms Class q and saltyp: Dcip=S Dna=R RI RR R1 Ra Rb Re Rl Rk ~&sal If Ciprofloxacin is S and Nalidixic Acid is R, report isolate comment This isolate is tested Fluoroquinolone-susceptible and nalidixic acid-resistant; may be associated with clinical failure or delayed response in fluoroquinolone-treated patients with extraintesinal salmonellosis. For M. catarrhalis - LIS Isolate Canned Message Code: \mcat; attached to Organism: "The majority of Moraxella catarrhalis are resistant to ampicillin. In vitro susceptibility testing for this organism is not routinely performed and/or is unreliable. If advice on antimicrobial therapy is required, please contact the Medical Microbiologist". B. Canned to be selected from the Isolate Comment keypad: The listed below are canned messages to be selected from the Isolate Comment keypad when needed. 1. At the LIS Isolate Comment Window, type the appropriate number on the keypad. 2. Press F12 to save. 3. Continue with another F12 to save the order. 4. View the report. 5. Status the report as required. For INH reporting if 0.1 mg/l=r and 0.4mg/L=S: LIS Isolate Canned Message Code: \INHr; select from keypad This isolate has low-level resistance to isoniazid (INH). Patients infected with strains exhibiting this level of INH resistance may benefit from continuing therapy with INH. Consultation with a specialist experienced in the treatment of tuberculosis is recommended. BORSA (DENKA meca-negative S. aureus with oxacillin MIC>=4mg/L) LIS Isolate Canned Message Code: \BORS; select from Isolate Keypad This organism is resistant to cloxacillin by a mechanism different from that in typical MRSA. Consultation with a Microbiologist or Infectious Disease physician is advised. Page 29

Policy # MI\ANTI\04\v01 Page 5 of 5 If susceptibility is done on request for ß-haemolytic Streptococcus Groups A, B, C & G Do not remove original canned message. Add message from Isolate Comment keypad code Susceptibility\done Susceptibility completed as requested. Enterococcus from Blood and Sterile Sites: If high level gentamicin is susceptible (regardless of streptomycin result), select from Isolate Comment Keypad \EGMS: Serious enterococcal infections may require an aminoglycoside for synergy. Please contact the Medical Microbiologist for treatment advice. If high level gentamicin is resistant (regardless of streptomycin result), select from Isolate Comment Keypad \EGMR: This organism is high level aminoglycoside resistant. Please contact the Medical Microbiologist for treatment advice. E. coli, Klebsiella species, Proteus cefpodoxime=i or R, set up KB ESBL, Preliminary Report Comment; select from ISOLATE keypad - \podr Susceptibility testing suggests that this organism may contain an extended spectrum betalactamase. Further testing is being completed and results will be available tomorrow. If you are interested in preliminary susceptibility results, please contact the microbiology laboratory. Page 30